Trial Profile
An observational study evaluating efficacy of prophylactic treatment for Plasmodium falciparum with atovaquone-proguanil in long-term travellers in West Africa.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Mar 2017
Price :
$35
*
At a glance
- Drugs Atovaquone/proguanil (Primary) ; Mefloquine
- Indications Falciparum malaria
- Focus Therapeutic Use
- 31 Mar 2017 New trial record